Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
35 Alpha-Glucosidase Inhibitors: These agents (e.g., acarbose, miglitol) work by reducing the rate of polysaccharide digestion from the gut and have been shown to augment incretin secretion
Limitations: Diagnostic codes specifically for NAION were lacking
What You May Notice Over Time
Cigna, Blue Cross Blue Shield, Medicare, Medicaid, Amerigroup, and Aetna may also provide varying levels of coverage contingent on clinical documentation and state guidelines
Randomised clinical trial: Significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea